Carolyn R. Bertozzi - Jan 5, 2023 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
Director
Signature
By: /s/ Andrew Mayer, Attorney-in-Fact For: Carolyn R. Bertozzi
Stock symbol
ALNY
Transactions as of
Jan 5, 2023
Transactions value $
$0
Form type
4
Date filed
1/9/2023, 03:06 PM
Previous filing
Jan 5, 2023
Next filing
Jun 27, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Stock Option (right to buy) Award $0 +4.27K $0.00 4.27K Jan 5, 2023 Common Stock 4.27K $225.68 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest as to one third of the shares on each of the first, second and third anniversaries of the date of grant.